- Kopetz, S., Grothey, A., Yaeger, R., Van Cutsem, E., Desai, J., Yoshino, T., Tabernero, et al. (2019). Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer. New England Journal of Medicine, 381(17), 1632-1643.
Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated colorectal cancer
on 2 de desembre de 2019
with No hi ha comentaris
Deixa un comentari